Roche Holding

ROP · SIX · CHF

CHF 345.70Change from previous close: −0.95%Absolute change: −CHF 3.30

Close · October 2, 2026

At a glance

Revenue growth
+1.54%
2025 vs 2024
Net income growth
+55.61%
2025 vs 2024
Net margin
20.3%
2024: 13.3%

Financial data

Amounts in millions of CHF; per-share values in CHF; shares in millions.

Cash flow · Quarterly
ItemQ2 2026Q4 2025Q2 2025Q4 2024Q2 2024Q4 2023Q2 2023Q4 2022Q2 2022Q4 2021
Operating cash flow7,63511,7527,10012,1807,9148,1977,8988,6329,17112,764
Depreciation and amortization1,7091,6881,6981,7691,6541,7141,7501,9441,9002,174
Capital expenditure-1,570-2,068-1,680-1,805-1,724-2,002-1,740-1,764-1,685-1,934
Investing cash flow2,419-10,3761,833-8,528-2,865-10,161-482-4,7351,811-6,596
Financing cash flow-10,181-3,245-8,123-1,370-5,4494,054-8,293-2,960-13,315-4,052
Dividends paid-7,802—-7,731—-7,650—-7,590—-7,446—
Share repurchases-107————————-18,991
Debt issued1,553-5143,7452,3105,6057,1041,2382919,44418,730
Debt repaid-1,949-1,072-2,678-2,425-2,021-2,017-879-2,125-13,713-2,492
Effect of exchange rates-7.0-103-231-131-152-434-394-261-202-266
Net change in cash-134-1,9725792,151-5521,656-1,271676-2,5351,850
Free cash flow6,0659,6845,42010,3756,1906,1956,1586,8687,48610,830
Levered free cash flow2,3337,9613,0438,6595,0083,1185,4875,1275,8058,232